Skip to content

Inspection Record

Tan-Alize Kozmetik ve Temizlik Urunleri Sanayi ve Ticaret A.S. — FDA 483 Findings

US FDAInspected 2026-02-27Published 2026-10-26 7 findingsLaboratory and QC controlsStability and storageDocumentation and recordsContamination controlEquipment and facilityProcess validation

Inspectors Saleem A AkhtarThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards and test procedures designed to assure that components, drug product containers and drug products conform to appropriate standards of identity, strength, quality and purity.

3Documentation and records

Batch production and control records do not include complete information relating to the production and control of each batch.

4Contamination control

Procedures designed to prevent objectionable microorganisms in drug products not required to be sterile are not followed.

5Equipment and facility

The production area air supply lacks an appropriate air filtration system.

6Laboratory and QC controls

Determinations of conformance to appropriate written specifications for acceptance are deficient for in- process materials.

7Process validation

Written production and process control procedures are not followed in the execution of production and process control functions and documented at the time ofperformance.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Tan-Alize Kozmetik ve Temizlik Urunleri Sanayi ve Ticaret A.S. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.